← Leaderboards
Rebecca J Abergel
University Of Calif-Lawrenc Berkeley Lab
$2,229,966
Attributed
$5,610,520
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2009–23$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,610,520 · 3
By mechanism
RC2$4,225,693 · 1
P01$889,342 · 1
R21$495,485 · 1
Top collaborators
- Eleanor A Blakely2 shared
- Polly Yee Chang2 shared
- Kenneth N Raymond2 shared
- David K Shuh2 shared
Most similar at University Of Calif-Lawrenc Berkeley Lab
Same institution · by research overlap
- Daojing Wang$14,771,713
- Martha R Stampfer$2,755,184
- Amy Kronenberg$2,254,964
- Eleanor A Blakely$845,139
- Polly Yee Chang$16,021,910
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignActinoid Series ElementsToxic EffectLaboratoriesComplexChelating AgentsExcisionLigandsNuclearDoseRadioisotopesIn VivoPlutoniumProgramsRadiationExposure ToAcidsExposed Human PopulationIonsBiologyEventEnvironmental PollutionChemistryInterest
Grant awards (6)
Project 4: Post-Exposure Biomarkers and Remediation of Radionuclide Contaminants$514,890
P01 · FY2023 · AI · contact PI
Project 4: Post-Exposure Biomarkers and Remediation of Radionuclide Contaminants$374,452
P01 · FY2022 · AI · contact PI
Exploring the use of a hydroxypyridinone decorporation agent for the removal of toxic residual gadolinium from MRI contrast agent administration$232,460
R21 · FY2018 · EB · contact PI
Exploring the use of a hydroxypyridinone decorporation agent for the removal of toxic residual gadolinium from MRI contrast agent administration$263,025
R21 · FY2017 · EB · contact PI
Biomimetic Actinide Decorporation: Characterization and Preclinical Development$2,140,116
RC2 · FY2010 · AI
Biomimetic Actinide Decorporation: Characterization and Preclinical Development$2,085,577
RC2 · FY2009 · AI